BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 17032282)

  • 1. Third-line rescue therapy with levofloxacin is more effective than rifabutin rescue regimen after two Helicobacter pylori treatment failures.
    Gisbert JP; Gisbert JL; Marcos S; Moreno-Otero R; Pajares JM
    Aliment Pharmacol Ther; 2006 Nov; 24(10):1469-74. PubMed ID: 17032282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levofloxacin- vs. ranitidine bismuth citrate-containing therapy after H. pylori treatment failure.
    Gisbert JP; Gisbert JL; Marcos S; Moreno-Otero R; Pajares JM
    Helicobacter; 2007 Feb; 12(1):68-73. PubMed ID: 17241304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Third-line rescue therapy with levofloxacin after two H. pylori treatment failures.
    Gisbert JP; Castro-Fernández M; Bermejo F; Pérez-Aisa A; Ducons J; Fernández-Bermejo M; Bory F; Cosme A; Benito LM; López-Rivas L; Lamas E; Pabón M; Olivares D;
    Am J Gastroenterol; 2006 Feb; 101(2):243-7. PubMed ID: 16454825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Empirical Helicobacter pylori "rescue" therapy after failure of two eradication treatments.
    Gisbert JP; Gisbert JL; Marcos S; Pajares JM
    Dig Liver Dis; 2004 Jan; 36(1):7-12. PubMed ID: 14971810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fourth-line rescue therapy with rifabutin in patients with three Helicobacter pylori eradication failures.
    Gisbert JP; Castro-Fernandez M; Perez-Aisa A; Cosme A; Molina-Infante J; Rodrigo L; Modolell I; Cabriada JL; Gisbert JL; Lamas E; Marcos E; Calvet X
    Aliment Pharmacol Ther; 2012 Apr; 35(8):941-7. PubMed ID: 22372560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
    Köksal AS; Parlak E; Filik L; Yolcu OF; Odemiş B; Ulker A; Saşmaz N; Ozden A; Sahin B
    J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of rifabutin-based triple therapy as second-line treatment to eradicate helicobacter pylori infection.
    Navarro-Jarabo JM; Fernández N; Sousa FL; Cabrera E; Castro M; Ramírez LM; Rivera R; Ubiña E; Vera F; Méndez I; Rivas-Ruiz F; Moreno JL; Perea-Milla E
    BMC Gastroenterol; 2007 Jul; 7():31. PubMed ID: 17651479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 7-day rescue therapy with ranitidine bismuth citrate after Helicobacter pylori treatment failure.
    Gisbert JP; Fuentes J; Carpio D; Tito L; Guardiola J; Tomas A; Olivares D; Calvet X
    Aliment Pharmacol Ther; 2005 May; 21(10):1249-53. PubMed ID: 15882246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trial: clarithromycin vs. levofloxacin in first-line triple and sequential regimens for Helicobacter pylori eradication.
    Molina-Infante J; Perez-Gallardo B; Fernandez-Bermejo M; Hernandez-Alonso M; Vinagre G; Dueñas C; Mateos-Rodriguez JM; Gonzalez-Garcia G; Abadia EG; Gisbert JP
    Aliment Pharmacol Ther; 2010 May; 31(10):1077-84. PubMed ID: 20180787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infection.
    Wong WM; Gu Q; Chu KM; Yee YK; Fung FM; Tong TS; Chan AO; Lai KC; Chan CK; Wong BC
    Aliment Pharmacol Ther; 2006 Feb; 23(3):421-7. PubMed ID: 16423001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cumulative H. pylori eradication rates in clinical practice by adopting first and second-line regimens proposed by the Maastricht III consensus and a third-line empirical regimen.
    Rokkas T; Sechopoulos P; Robotis I; Margantinis G; Pistiolas D
    Am J Gastroenterol; 2009 Jan; 104(1):21-5. PubMed ID: 19098844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second-line rescue therapy with levofloxacin after H. pylori treatment failure: a Spanish multicenter study of 300 patients.
    Gisbert JP; Bermejo F; Castro-Fernández M; Pérez-Aisa A; Fernández-Bermejo M; Tomas A; Barrio J; Bory F; Almela P; Sánchez-Pobre P; Cosme A; Ortiz V; Niño P; Khorrami S; Benito LM; Carneros JA; Lamas E; Modolell I; Franco A; Ortuño J; Rodrigo L; García-Durán F; O'Callaghan E; Ponce J; Valer MP; Calvet X;
    Am J Gastroenterol; 2008 Jan; 103(1):71-6. PubMed ID: 17764498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High efficacy of 1-week doxycycline- and amoxicillin-based quadruple regimen in a culture-guided, third-line treatment approach for Helicobacter pylori infection.
    Cammarota G; Martino A; Pirozzi G; Cianci R; Branca G; Nista EC; Cazzato A; Cannizzaro O; Miele L; Grieco A; Gasbarrini A; Gasbarrini G
    Aliment Pharmacol Ther; 2004 Apr; 19(7):789-95. PubMed ID: 15043520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Empirical rescue therapy after Helicobacter pylori treatment failure: a 10-year single-centre study of 500 patients.
    Gisbert JP; Gisbert JL; Marcos S; Jimenez-Alonso I; Moreno-Otero R; Pajares JM
    Aliment Pharmacol Ther; 2008 Feb; 27(4):346-54. PubMed ID: 17999716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levofloxacin- versus metronidazole-based rescue therapy for H. pylori infection in Japan.
    Matsumoto Y; Miki I; Aoyama N; Shirasaka D; Watanabe Y; Morita Y; Toyoda M; Mitani T; Miyachi H; Tamura T; Kasuga M
    Dig Liver Dis; 2005 Nov; 37(11):821-5. PubMed ID: 16040284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second-line rescue triple therapy with levofloxacin after failure of non-bismuth quadruple "sequential" or "concomitant" treatment to eradicate H. pylori infection.
    Gisbert JP; Molina-Infante J; Marin AC; Vinagre G; Barrio J; McNicholl AG
    Scand J Gastroenterol; 2013 Jun; 48(6):652-6. PubMed ID: 23556551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second-line therapy with levofloxacin after failure of treatment to eradicate helicobacter pylori infection: time trends in a Spanish Multicenter Study of 1000 patients.
    Gisbert JP; Pérez-Aisa A; Bermejo F; Castro-Fernández M; Almela P; Barrio J; Cosme A; Modolell I; Bory F; Fernández-Bermejo M; Rodrigo L; Ortuño J; Sánchez-Pobre P; Khorrami S; Franco A; Tomas A; Guerra I; Lamas E; Ponce J; Calvet X;
    J Clin Gastroenterol; 2013 Feb; 47(2):130-5. PubMed ID: 22647827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second-line and rescue therapies for Helicobacter pylori eradication in clinical practice.
    Zullo A; De Francesco V; Manes G; Scaccianoce G; Cristofari F; Hassan C
    J Gastrointestin Liver Dis; 2010 Jun; 19(2):131-4. PubMed ID: 20593044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clarithromycin-amoxycillin-containing triple therapy: a valid empirical first-line treatment for Helicobacter pylori eradication in Hong Kong?
    Hung IF; Chan P; Leung S; Chan FS; Hsu A; But D; Seto WK; Wong SY; Chan CK; Gu Q; Tong TS; Cheung TK; Chu KM; Wong BC
    Helicobacter; 2009 Dec; 14(6):505-11. PubMed ID: 19889067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori first-line treatment and rescue options in patients allergic to penicillin.
    Gisbert JP; Gisbert JL; Marcos S; Olivares D; Pajares JM
    Aliment Pharmacol Ther; 2005 Nov; 22(10):1041-6. PubMed ID: 16268980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.